{"id":"https://openalex.org/W2597789345","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps7124","title":"Treatment-free remission (TFR) following nilotinib (NIL) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath.","display_name":"Treatment-free remission (TFR) following nilotinib (NIL) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom, ENESTop, ENESTgoal, and ENESTpath.","publication_year":2014,"publication_date":"2014-05-20","ids":{"openalex":"https://openalex.org/W2597789345","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps7124","mag":"2597789345"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.15_suppl.tps7124","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps7124","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps7124","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075844368","display_name":"Fran\u00e7ois\u2010Xavier Mahon","orcid":"https://orcid.org/0000-0003-1545-6775","observed_orcids":["https://orcid.org/0000-0003-1545-6775"]},"institutions":[{"id":"https://openalex.org/I4405256745","display_name":"Universit\u00e9 Bordeaux Segalen","ror":"https://ror.org/04gbzm373","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530","https://openalex.org/I4405256745"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Francois-Xaxier Mahon","raw_affiliation_strings":["Universit\u00e9 Victor S\u00e9galen, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universit\u00e9 Victor S\u00e9galen, Bordeaux, France","institution_ids":["https://openalex.org/I4405256745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044224344","display_name":"Michele Baccarani","orcid":"https://orcid.org/0000-0003-1999-1687","observed_orcids":["https://orcid.org/0000-0003-1999-1687"]},"institutions":[{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Baccarani","raw_affiliation_strings":["University of Bologna, Bologna, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Bologna, Bologna, Italy","institution_ids":["https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015789771","display_name":"Michael J. Mauro","orcid":"https://orcid.org/0000-0002-2251-4032","observed_orcids":["https://orcid.org/0000-0002-2251-4032"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael J. Mauro","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center, New York, NY","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049971021","display_name":"Timothy P. Hughes","orcid":"https://orcid.org/0000-0002-0910-3730","observed_orcids":["https://orcid.org/0000-0002-0910-3730","https://orcid.org/0000-0002-8721-4719"]},"institutions":[{"id":"https://openalex.org/I107656453","display_name":"South Australia Pathology","ror":"https://ror.org/01kvtm035","country_code":"AU","type":"nonprofit","lineage":["https://openalex.org/I107656453"]},{"id":"https://openalex.org/I4210137740","display_name":"South Australian Health and Medical Research Institute","ror":"https://ror.org/03e3kts03","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210137740"]},{"id":"https://openalex.org/I4210140852","display_name":"Centre for Cancer Biology","ror":"https://ror.org/03yg7hz06","country_code":"AU","type":"facility","lineage":["https://openalex.org/I107656453","https://openalex.org/I4210140852","https://openalex.org/I4405259444"]},{"id":"https://openalex.org/I5681781","display_name":"The University of Adelaide","ror":"https://ror.org/00892tw58","country_code":"AU","type":"education","lineage":["https://openalex.org/I4405259444","https://openalex.org/I5681781"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Timothy P. Hughes","raw_affiliation_strings":["South Australian Health and Medical Research Institute, University of Adelaide, Division of Haematology and Centre for Cancer Biology, SA Pathology, Adelaide, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"South Australian Health and Medical Research Institute, University of Adelaide, Division of Haematology and Centre for Cancer Biology, SA Pathology, Adelaide, Australia","institution_ids":["https://openalex.org/I107656453","https://openalex.org/I4210137740","https://openalex.org/I4210140852","https://openalex.org/I5681781"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019949455","display_name":"Giuseppe Nicola Saglio","orcid":"https://orcid.org/0000-0002-1046-3514","observed_orcids":["https://orcid.org/0000-0002-1046-3514"]},"institutions":[{"id":"https://openalex.org/I4210155833","display_name":"Ospedale San Luigi Gonzaga","ror":"https://ror.org/04nzv4p86","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210155833"]},{"id":"https://openalex.org/I55143463","display_name":"University of Turin","ror":"https://ror.org/048tbm396","country_code":"IT","type":"education","lineage":["https://openalex.org/I55143463"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuseppe Saglio","raw_affiliation_strings":["University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Turin, San Luigi Gonzaga Hospital, Orbassano, Italy","institution_ids":["https://openalex.org/I4210155833","https://openalex.org/I55143463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049400849","display_name":"Michael Robert Savona","orcid":"https://orcid.org/0000-0003-3763-5504","observed_orcids":["https://orcid.org/0000-0003-3763-5504"]},"institutions":[{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Savona","raw_affiliation_strings":["Tennessee Oncology, Nashville, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tennessee Oncology, Nashville, TN","institution_ids":["https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004871362","display_name":"Tomasz K. Szczudlo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomasz K. Szczudlo","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084826274","display_name":"Hans Dietrich Menssen","orcid":"https://orcid.org/0000-0002-1895-4713","observed_orcids":["https://orcid.org/0000-0002-1895-4713"]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Hans D. Menssen","raw_affiliation_strings":["Novartis Pharma AG, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma AG, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110018371","display_name":"Christopher Hunt Keir","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Hunt Keir","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074751417","display_name":"Claudia Walasek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210155630","display_name":"Novartis (Austria)","ror":"https://ror.org/04t24x986","country_code":"AT","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210155630"]}],"countries":["AT"],"is_corresponding":false,"raw_author_name":"Claudia Walasek","raw_affiliation_strings":["Novartis Pharma GmbH, Wien, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharma GmbH, Wien, Austria","institution_ids":["https://openalex.org/I4210155630"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035964802","display_name":"Andreas Hochhaus","orcid":"https://orcid.org/0000-0003-0626-0834","observed_orcids":["https://orcid.org/0000-0003-0626-0834"]},"institutions":[{"id":"https://openalex.org/I4210134900","display_name":"Jena University Hospital","ror":"https://ror.org/035rzkx15","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210134900"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Hochhaus","raw_affiliation_strings":["Abteilung H\u00e4matologie/Onkologie, Universit\u00e4tsklinikum Jena, Jena, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Abteilung H\u00e4matologie/Onkologie, Universit\u00e4tsklinikum Jena, Jena, Germany","institution_ids":["https://openalex.org/I4210134900"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"15_suppl","first_page":"TPS7124","last_page":"TPS7124"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":0.9409999847412109},{"id":"https://openalex.org/keywords/chronic-myeloid-leukemia","display_name":"chronic myeloid leukemia","score":0.9380000233650208},{"id":"https://openalex.org/keywords/chronic-phase","display_name":"chronic phase","score":0.9539999961853027},{"id":"https://openalex.org/keywords/treatment-free-remission","display_name":"treatment-free remission","score":0.9959999918937683},{"id":"https://openalex.org/keywords/bcr-abl","display_name":"BCR-ABL","score":0.6309999823570251},{"id":"https://openalex.org/keywords/molecular-response","display_name":"molecular response","score":0.6859999895095825},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.6060000061988831},{"id":"https://openalex.org/keywords/imatinib","display_name":"imatinib","score":0.6729999780654907},{"id":"https://openalex.org/keywords/molecular-relapse","display_name":"molecular relapse","score":0.781000018119812},{"id":"https://openalex.org/keywords/molecular-monitoring","display_name":"molecular monitoring","score":0.32600000500679016},{"id":"https://openalex.org/keywords/reinitiation","display_name":"reinitiation","score":0.42500001192092896}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8589484691619873},{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.8054718971252441},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5754153728485107},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.517711877822876},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.49567902088165283},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.44392505288124084},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4315102696418762},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3633408546447754},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3559954762458801},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3434062600135803},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3229910731315613}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.15_suppl.tps7124","doi":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps7124","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.15_suppl.tps7124","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2483445141","https://openalex.org/W2962662019","https://openalex.org/W3213735731","https://openalex.org/W2890755736","https://openalex.org/W2523106824","https://openalex.org/W2484566282","https://openalex.org/W2980243952","https://openalex.org/W7124768790","https://openalex.org/W2888775722","https://openalex.org/W2891287398"],"abstract_inverted_index":{"TPS7124":[0],"Background:":[1],"Approximately":[2],"40%":[3],"of":[4,34,148,194,216,327,330,335,339,342,347],"pts":[5,44,65,79,93,118,134,141,176,197],"who":[6,137,144],"achieve":[7,46,138,152],"deep,":[8,35],"sustained":[9,36],"molecular":[10,82,210,352],"response":[11,284,353],"(MR)":[12],"on":[13,99,104,122,219],"imatinib":[14],"(IM)":[15],"are":[16,124],"able":[17],"to":[18,45,126,132,160,183,247,312,323],"successfully":[19],"maintain":[20,178],"TFR":[21,61,87,188,192,218,316],"(Mahon":[22],"FX,":[23],"et":[24],"al.":[25],"Lancet":[26],"Oncol.":[27],"2010;11:1029-1035).":[28],"NIL":[29,63,74,105,127,149,220,251,256,288,309],"results":[30],"in":[31,64,135,142,224],"higher":[32],"rates":[33],"MR":[37,121,173,203,306],"vs":[38],"IM":[39,123,265,269],"and":[40,59,91,116,140,151,214],"may":[41],"enable":[42],"more":[43],"successful":[47,217],"TFR.":[48],"Four":[49],"ongoing":[50],"studies":[51],"will":[52,157,221],"evaluate":[53],"the":[54,100,108,180,187,191],"key":[55],"factors":[56],"for":[57,186,315],"achieving":[58],"sustaining":[60],"following":[62],"with":[66,94],"CML-CP":[67],"(Table).":[68],"Methods:":[69],"Each":[70,167],"study":[71,168],"includes":[72],"a":[73,86,161,171,206],"consolidation":[75,110,165,181,289,310],"phase,":[76],"during":[77,179,308],"which":[78],"undergo":[80],"frequent":[81],"monitoring,":[83],"followed":[84],"by":[85],"phase.":[88,166,189],"In":[89,114],"ENESTfreedom":[90,231],"ENESTop,":[92],"MR4.5":[95,139,276,277,281,318,319,320],"(BCR-ABL":[96],"\u2264":[97,155,355],"0.0032%":[98],"international":[101],"scale":[102],"[BCR-ABLIS])":[103],"directly":[106],"enter":[107],"1-y":[109],"phase":[111,182,193,290,311,317],"upon":[112,128],"enrollment.":[113],"ENESTgoal":[115,136,235],"ENESTpath,":[117],"without":[119],"deep":[120],"switched":[125],"enrollment;":[129],"after":[130],"switching":[131],"NIL,":[133],"ENESTpath":[143,237],"complete":[145],"2":[146,253,262,271,299,304],"y":[147,259,263,293,295,297,300,302,305],"therapy":[150,200,325],"MR4":[153,287,321,336,340,348],"(BCR-ABLIS":[154,354],"0.01%)":[156],"be":[158,184,222,313],"randomized":[159],"1-":[162],"or":[163,298,303,332,344],"2-y":[164],"protocol":[169],"defines":[170],"required":[172,307],"level":[174],"that":[175],"must":[177,198],"eligible":[185,314],"During":[190],"each":[195,225],"study,":[196],"re-initiate":[199,324],"if":[201],"their":[202],"rises":[204],"above":[205],"defined":[207],"threshold":[208],"(ie,":[209],"relapse).":[211],"The":[212],"rate":[213],"duration":[215,291],"evaluated":[223],"study.":[226],"Clinical":[227],"trial":[228],"information:":[229],"NCT01784068.":[230],"NCT01784068":[232],"ENESTop":[233],"NCT01698905":[234],"NCT01744665":[236],"NCT01743989":[238],"Planned":[239],"N":[240],"175":[241],"117":[242],"300":[243],"1,058":[244],"Treatment":[245],"prior":[246],"enrollment":[248,275],"(duration)":[249],"Frontline":[250],"(\u2265":[252,257,266,270],"y)":[254,268,272],"Second-line":[255],"3":[258],"total;":[260],"\u2265":[261],"NIL)":[264],"1":[267,292,294,296,301],"Response":[273],"at":[274],"MMR":[278,328,331,343],"but":[279,285],"not":[280,286],"Complete":[282],"cytogenetic":[283],"Trigger":[322],"Loss":[326,329,341],"confirmed":[333,345],"loss":[334,338,346],"Confirmed":[337],"Abbreviations:":[349],"MMR,":[350],"major":[351],"0.1%).":[356]},"counts_by_year":[{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-04-07T00:00:00"}